Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-13

FDA Approved: SUCRALFATE — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Cosette Pharmaceuticals' generic sucralfate under an original ANDA for short-term treatment and maintenance of duodenal ulcers and treatment of gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUCRALFATE (SUCRALFATE)

Snippet

ORIG AP for SUCRALFATE (SUCRALFATE)